Highlights General Biologicals Corporation

Equities

4117

TW0004117007

End-of-day quote Taipei Exchange Other stock markets 23:00:00 23/05/2024 BST			5-day change	1st Jan Change
21 ^TWD	+0.96%		-5.41%	-22.22%

04-30	General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	General Biologicals Corporation Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	04-30	CI
General Biologicals Corporation Reports Earnings Results for the Half Year Ended June 30, 2023	14/08/23	CI
General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	28/04/23	CI
General Biologicals Corporation Reports Earnings Results for the Half Year Ended June 30, 2022	12/08/22	CI
General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	27/04/22	CI
General Biologicals Corporation Reports Earnings Results for the Half Year Ended June 30, 2021	12/08/21	CI
General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2020	29/04/21	CI
General Biologicals Corporation completed the acquisition of additional 77% stake in Pacgen Life Science Corporation.	29/09/20	CI
General Biologicals Corporation Reports Earnings Results for the Half Year Ended June 30, 2020	13/08/20	CI
General Biologicals Corporation entered into a letter of intent to acquire additional 77% stake in Pacgen Life Science Corporation for CAD 1.4 million.	06/07/20	CI
General Biologicals Corporation Announces Develops Covid-19 Testing Solutions for Antigen and Antibody Detection	06/07/20	CI
General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2019	28/04/20	CI
General Biologicals Corporation Reports Earnings Results for the Half Year Ended June 30, 2019	13/08/19	CI
General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2018	29/04/19	CI
General Biologicals Corporation Adds New Markets for P113 Products Licensed from Pacgen	24/01/17	CI
GBC Introduces its New Discovery Line of Document Cameras	07/11/16	CI
General Biologicals Corporation Makes Significant Progress on PAC-113	16/08/16	CI
General Biologicals Provides Update on Licensed Product, PAC-113	19/10/15	CI
General Biologicals Corporation Signs American Laboratory Products Company, Ltd Distribution Agreement	17/12/12	CI
Pacgen Biopharmaceuticals Corporation cancelled the acquisition of the business and operating assets of CurieMed Corporation from General Biologicals Corporation.	14/03/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights General Biologicals Corporation

Equities

4117

TW0004117007

Highlights

Filters